ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The potential mechanism of Bupleurum against anxiety was predicted by network pharmacology study and molecular docking

Wu, Han-Biao; Xiao, Yu-Gang; Chen, Ji-Sheng; Qiu, Zhi-Kun*广东药学院; 1
Metabolic Brain Disease2022-6DOI: 10.1007/s11011-022-00970-1
4被引16阅读
引用收藏
分享

摘要

Bupleurum chinense DC. (Chaihu) is a traditional Chinese medicine (TCM) used in the treatment of anxiety. But the anxiolytic mechanisms of bupleurum are still unclear. Therefore, this unknown is predicted by network pharmacology study with molecular docking in the present study. The components of bupleurum were obtained from the databases. Genes associated with components and disease were also provided by databases. Overlapping genes between components and disease were analyzed. The network of medicine-components-targets-disease was constructed, visualized, and analyzed. Protein-protein interaction (PPI), gene ontology (GO), pathway enrichment (KEGG) and molecular docking were conducted to predict the potential mechanisms of bupleurum on anxiety. A total of 9 bioactive components derived from bupleurum with 80 target genes were involved in anxiety. Neurotransmitter receptor activity, G protein-coupled amine receptor activity, regulation of blood circulation, neuroactive ligand-receptor interaction, calcium signaling pathway and salivary secretion may play significant roles in the anxiolytic of bupleurum. Molecular docking implicated that ACHE and MAOA showed high affinity for stigmasterol. Based on network pharmacology study with molecular docking, multi-component-multi-target-multi-pathway action mode of bupleurum on anxiety was elaborated. Stigmasterol might be the core bioactive component, while ACHE and MAOA might be the core target genes in the pharmacological profile of bupleurum on anxiety.

学科与关键词

关键词
Network pharmacology studyMolecular dockingbupleurumAnxietySignaling pathway
相关
加载中…
  • Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of depression
    Du, Li-Jing; Zhang, Xin-Ning; Li, Sha-Sha; Sun, Yuan-Fang; Jin, Hui-Zi; Yan, Shi-Kai*; Han, Chuan-Gang*Metabolic Brain Disease, 2022, 37(8): 2903-2914.被引 2
  • Exploring the potential mechanism of Kaixinsan powder for the same pathogenesis of PTSD and anxiety based on network pharmacology and molecular docking: A review
    Li, Wen-Wei; Wang, Jia; Wu, Han-Biao; Qiu, Zhi-Kun*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(46): e35869.
  • Exploring the Potential Antidepressant Mechanisms of Pinellia by Using the Network Pharmacology and Molecular Docking
    Xiao, Yu-Gang; Wu, Han-Biao; Chen, Ji-Sheng; Li, Xiong*; Qiu, Zhi-Kun*Metabolic Brain Disease, 2022, 37(4): 1071-1094.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Metabolic Brain Disease
发表日期
2022-06
卷期
第 37 卷, 第 5 期
页码
1609-1639
DOI
10.1007/s11011-022-00970-1
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Key Clinical Specialty Construction Project (Clinical Pharmacy); High Level Clinical Key Specialty (Clinical Pharmacy) in Guangdong Province; Guangdong province hospital association [2021YXQN08]

作者

  • W

    Wu, Han-Biao (第一作者)

    1 · guangdong pharmaceut univ

  • X

    Xiao, Yu-Gang

    1 · guangdong pharmaceut univ

查看全部 4 位作者收起作者
  • C

    Chen, Ji-Sheng

    1 · guangdong pharmaceut univ

  • Q

    Qiu, Zhi-Kun (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417